fig1

Receptor-mediated brain delivery in MPS II: a platform turning point for rare disease therapeutics

Figure 1. Mechanism of TfR-mediated ERT strategies. Following transcytosis, neuronal cells take up the TfR-ERT complexes via M6PRs and TfRs. TfR: Transferrin receptor; M6PR: mannose-6-phosphate receptor; ERT: enzyme replacement therapy; TfR-ERT: transferrin receptor-mediated enzyme replacement therapy.

Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/